SEC Form 4 · accession 0001140361-15-021653
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E Daley
Officer — Chief Business Officer
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 9:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 20, 2015 | S | 10,000 | $12.00 | D | 64,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014.
- F2Includes 11,500 Restricted Stock Units ("RSUs") granted on February 9, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof.